Tower Research Capital LLC (TRC) - ATHIRA PHARMA INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q3 2023$327
+1386.4%
162
-98.2%
0.00%
-100.0%
Q1 2023$22
-68.6%
8,821
-59.8%
0.00%
-66.7%
Q4 2022$70
-99.9%
21,966
+22.1%
0.00%
+200.0%
Q3 2022$53,000
+783.3%
17,991
+853.9%
0.00%
Q2 2022$6,000
-68.4%
1,886
+37.1%
0.00%
Q1 2022$19,000
+90.0%
1,376
+83.7%
0.00%
Q4 2021$10,000
-69.7%
749
-78.4%
0.00%
-100.0%
Q3 2021$33,000
+17.9%
3,462
+28.0%
0.00%0.0%
Q2 2021$28,000
+40.0%
2,704
+144.3%
0.00%
Q1 2021$20,000
+42.9%
1,107
+172.0%
0.00%
Q4 2020$14,0004070.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Logos Global Management LP 1,630,744$21,249,0002.19%
VR Adviser, LLC 1,000,000$13,030,0001.78%
ACUTA CAPITAL PARTNERS, LLC 310,030$4,040,0001.70%
Ikarian Capital, LLC 860,000$11,207,0001.67%
Bristlecone Advisors, LLC 761,563$9,923,0001.19%
Perceptive Advisors 6,851,832$89,280,0000.69%
DAFNA Capital Management LLC 160,983$2,098,0000.53%
PATHSTONE FAMILY OFFICE, LLC 1,442,247$18,792,0000.47%
Potomac Capital Management, Inc. 40,000$521,0000.46%
RTW INVESTMENTS, LP 1,906,557$24,842,0000.36%
View complete list of ATHIRA PHARMA INC shareholders